Example datasets for use with [CNVkit](http://github.com/etal/cnvkit), derived
from sequencing data from these published studies:

Targeted & exome (desmoplastic melanoma):

    Shain, A.H., Garrido, M., Botton, T., Talevich, E., Yeh, I., Sanborn, J.
    Z., Chung, J., Wang, N.J., Kakavand, H.  Mann, G.J., Thompson, J.F.,
    Wiesner, T., Roy, R., Olshen, A.B., Gagnon, A., Gray, J.W., Huh, N., Hur,
    J.S., Busam, K.J., Scolyer, R.A., Cho, R.J., Murali, R., Bastian, B.C.
    (2015).
    Exome sequencing of desmoplastic melanoma identifies recurrent NFKBIE
    promoter mutations and diverse activating mutations in the MAPK pathway.
    Nature Genetics.
    [doi:10.1038/ng.3382](http://dx.doi.org/10.1038/ng.3382)

Cell line (C0902):

    Botton, T., Yeh, I., Nelson, T., Vemula, S.S., Sparatta, A., Garrido, M.C.,
    Allegra, M., Rocchi, S., Bahadoran, P., Mccalmont, T.H., Leboit, P.E.,
    Burton, E.A., Bollag, G., Ballotti, R., Bastian, B.C. (2013).
    Recurrent BRAF kinase fusions in melanocytic tumors offer an opportunity
    for targeted therapy.
    Pigment Cell and Melanoma Research, 26, 845â€“851.
    [doi:10.1111/pcmr.12148](http://dx.doi.org/10.1111/pcmr.12148)

See also the [CNVkit preprint manuscript](http://dx.doi.org/10.1101/010876).
